Clinical trials
3 active studies led by ZetrOZ, Inc., of 18 in all
Source: ClinicalTrials.gov, Studies with ZetrOZ, Inc. (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
Free public records show ZetrOZ, Inc. in 2 of the markets we cover. It is not a key player in our research.
[1] ClinicalTrials.gov, Studies led by ZetrOZ, Inc. or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
3 active studies led by ZetrOZ, Inc., of 18 in all
Source: ClinicalTrials.gov, Studies with ZetrOZ, Inc. (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
5 510(k) clearances and PMA approvals since 2015
Source: FDA 510(k) and PMA databases, 510(k) clearances, and PMA approvals or changes, since 2015; newest shown. Retrieved 13 Nov 2026.
Studies ZetrOZ, Inc. leads, by the year they started and their phase
Source: ClinicalTrials.gov, Studies with ZetrOZ, Inc. or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Markets we cover where free public records show ZetrOZ, Inc.: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
The topics of the markets ZetrOZ, Inc. is in.
Stories on the topics ZetrOZ, Inc. works in.
An IOC study found 14.8% of supplements tested contained undeclared steroids. Sports nutrition now sells to…
Read
Creatine is one of the most studied supplements in sport. Now it is reaching everyday buyers. What the…
Read
Protein powders are everywhere. Active people need more protein, but most can get it from food.
Read